{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:34:36Z","timestamp":1790699676919,"version":"4.1.0"},"reference-count":36,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis Journal - Experimental, Translational and Clinical"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p> The prevalence of multiple sclerosis (MS)-related fatigue may have changed due to new diagnostic criteria and new disease modifying drugs. We aimed to assess the prevalence of fatigue in a contemporary MS cohort, and to explore associations between fatigue and clinical and demographic factors. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p> This is a cross-sectional study of the MS population in three Norwegian counties. Fatigue was assessed with the Fatigue Scale for Motor and Cognitive Functions (FSMC). We also assessed self-reported anxiety, depression and daytime sleepiness. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> The response rate was 64% (1599\/2512). The mean age of the participants was 52\u2009\u00b1\u200913\u2009years, median EDSS was 2.5 (IQR 1.5-3.0) and median disease duration from onset was 16\u2009years (IQR 8-25). We found a prevalence of fatigue of 81%. Women had a higher prevalence of fatigue than men (83% vs 78%, p\u2009=\u20090.02). The prevalence increased with age (p\u2009&lt;\u20090.001) and with increasing disease severity (p\u2009&lt;\u20090.001), but in multivariate analyses, only sex and disease severity remained independent determinants of fatigue. Anxiety, depression, and daytime sleepiness were more prevalent in patients with fatigue than in those without fatigue (all p-values\u2009&lt;\u20090.001). <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> The prevalence of fatigue is high in contemporary patients with MS. Fatigue is associated with female sex and level of disability, as well as with anxiety, depression and excessive daytime sleepiness. <\/jats:p><\/jats:sec>","DOI":"10.1177\/2055217321999826","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T01:28:15Z","timestamp":1616117295000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":31,"title":["High prevalence of fatigue in contemporary patients with multiple sclerosis"],"prefix":"10.1177","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9317-4901","authenticated-orcid":false,"given":"Line","family":"Broch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9408-7199","authenticated-orcid":false,"given":"Cecilia Smith","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi \u00d8yen","family":"Flemmen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Telemark HF, Skien, Norway"},{"name":"Institute of Health and Society, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Berg-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5shild","family":"Skardhamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Ormstad","sequence":"additional","affiliation":[{"name":"University of South-Eastern Norway, Notodden, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9127-6488","authenticated-orcid":false,"given":"Elisabeth Gulowsen","family":"Celius","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oslo University Hospital, Oslo, Norway"},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"bibr1-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514525871"},{"key":"bibr2-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12615"},{"key":"bibr3-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102352"},{"key":"bibr4-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520280085020"},{"key":"bibr5-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1191\/1352458505ms1204oa"},{"key":"bibr6-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1191\/1352458505ms1216oa"},{"key":"bibr7-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-6-100"},{"key":"bibr8-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30354-9"},{"key":"bibr9-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/798285"},{"key":"bibr10-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517709361"},{"key":"bibr11-2055217321999826","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00149"},{"key":"bibr12-2055217321999826","unstructured":"MS Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington, DC: Paralyzed Veterans of America, 1998."},{"key":"bibr13-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1586\/ern.10.99"},{"key":"bibr14-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1191\/1352458503ms943oa"},{"key":"bibr15-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.01.011"},{"key":"bibr16-2055217321999826","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2012-053"},{"key":"bibr17-2055217321999826","doi-asserted-by":"crossref","unstructured":"Thompson AJ, Banwell BL, Barkhof F, et\u00a0al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17: 162\u2013173.","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"bibr18-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa145"},{"key":"bibr19-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0041-4"},{"key":"bibr20-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"bibr21-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1177\/1352458509348519"},{"key":"bibr22-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(01)00296-3"},{"key":"bibr23-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2016.03.004"},{"key":"bibr24-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-008-0202-x"},{"key":"bibr25-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058643"},{"key":"bibr26-2055217321999826","volume-title":"Psychometric assessment of the Norwegian version of the hospital anxiety and depression scale (HADS)","author":"Leiknes K","year":"2016"},{"key":"bibr27-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444"},{"key":"bibr28-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516657439"},{"key":"bibr29-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000446"},{"key":"bibr30-2055217321999826","unstructured":"Simonsen CS, Flemmen H, Broch L, et\u00a0al.  The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression. J Neurol. 2020 Oct 22. doi: 10.1007\/s00415-020-10279-7. Online ahead of print.URL:https:\/\/pubmed.ncbi.nlm.nih.gov\/33090270\/"},{"key":"bibr31-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.117"},{"key":"bibr32-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106265"},{"key":"bibr33-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.743"},{"key":"bibr34-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027070"},{"key":"bibr35-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.07.017"},{"key":"bibr36-2055217321999826","doi-asserted-by":"publisher","DOI":"10.1177\/135245850000600213"}],"container-title":["Multiple Sclerosis Journal - Experimental, Translational and Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2055217321999826","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2055217321999826","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2055217321999826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T05:41:32Z","timestamp":1740894092000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2055217321999826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1177\/2055217321999826"],"URL":"https:\/\/doi.org\/10.1177\/2055217321999826","relation":{},"ISSN":["2055-2173","2055-2173"],"issn-type":[{"value":"2055-2173","type":"print"},{"value":"2055-2173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"article-number":"2055217321999826"}}